News & Events
-
September 20, 2023
The CPP Consortium Welcomes Biohaven as its Newest Member
The Critical Path for Parkinson’s Consortium is excited to welcome Biohaven as its newest member. Biohaven is a biopharmaceutical company aimed at discovering and developing novel life-changing therapies for people living with neurological and neuropsychiatric diseases by collaborating with leaders in scientific discovery and medicine. CPP is excited to work with Biohaven as one of many new members from... -
September 18, 2023
C-Path and EATRIS Join Forces with New Collaboration Agreement
AMSTERDAM and TUCSON, Ariz., September 18, 2023 — Critical Path Institute (C-Path) and EATRIS (the European Research Infrastructure for Translational Medicine) are pleased to announce the signing of a collaboration agreement aimed at fostering actionable scientific and educational cooperation. This agreement marks a significant milestone in the pursuit of patient-centric innovation and the advancement of... -
September 12, 2023
C-Path’s Rare Disease Clinical Outcome Assessment Consortium Launches Rare Disease COA Resource
The Rare Disease COA Resource aims to simplify COA selection for use in rare disease drug development. TUCSON, Ariz., September 12, 2023 — The Rare Disease Clinical Outcome Assessment (COA) Consortium at Critical Path Institute (C-Path), a public-private partnership focused on optimizing COA selection during drug development for rare diseases, today announced the launch... -
September 11, 2023 - September 13, 2023
2023 Rare and Orphan Disease Conference presented by C-Path
Patients, providers, researchers, clinicians, biopharmaceutical companies, regulatory reviewers and scientists will leave this 2.5-day conference with an understanding of: C-Path’s Rare and Orphan Disease Program’s current and future impact on drug development in rare diseases The Critical Path for Rare Neurodegenerative Diseases (CP-RND) initiative’s first year impact and highlights How RDCA-DAP has been enhanced... -
August 30, 2023
NIDDK Central Repository 20th Anniversary Workshop: Promoting Secondary Research to Accelerate Medical Breakthroughs and Innovation
The National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) workshop highlights secondary use research that utilized resources generated from NIDDK-funded clinical research projects. The event also offers a review of NIDDK’s Data Ecosystem past, present, and future and launches a data challenge platform as part of the program’s vision for the future. C-Path’s T1D...